BBMRI - Biobanking and Biomolecular Resources Research Infrastructure

The Biobanking and Biomolecular Resources Research Infrastructure (BBMRI) was set up in 2008 to coordinate a large scale network to share access to available biological samples in Europe. This infrastructure will cover major biobanks, molecular resources and biocomputing centres to ensure that the samples are linked to existing databases, scientific literature and statistical expertise.

Biological resources are considered the essential raw material for the advancement of biotechnology, human health and R&D in life sciences. If well connected, catalogued and accessible, biobanks provide a crucial resource for academic and industry-based research to treat and prevent human diseases.

Building on existing infrastructures, resources and technology, BBMRI will allow the identification of disease genes and help define the relationships between genetics, the environment and lifestyle. A sharper biology-based definition of disease categories will enhance the development of more effective treatments, reduce undesired and unintended side effects and improve clinical trials design.

This unprecedented network could allow people to become aware of their potential to develop specific conditions, opening the possibility of personalised medicine (programmes and treatments). At the same time, BBMRI will support policy and scientific momentum to harmonise ethical, legal and quality standards across Europe.

BBMRI is one of the 44 initiatives selected for funding by the European Strategic Forum on Research Infrastructures (ESFRI). The forum brings together senior science policy officials representing the member state ministers, and a senior policy official form the EU Commission. They have prepared a Roadmap that identifies pan-European Research Infrastructures (RI) of crucial importance to strengthen the European Research Area, in particular for capacity building.

These projects have received financial support within the EU's Seventh Framework Programme for research and technological development and demonstration. It will cover the initial set up stage that should allow the different initiatives to define and develop mechanisms that can provide the necessary funding after the preparatory phase. 5€ million have been granted to the BBMRI to lay out the construction and operational process that will make its continuation possible.

The members of BBMRI have started preparing an inventory of European resources. They have identified a total of 92 biobanks so far. The biggest challenges they will face in the set up of the network will have to do with the harmonisation of policies and standards, the establishment of a data protection systems and the definition of the legal, ethical and financial governance of this new research infrastructure.

For further information, please visit:
http://www.bbmri.eu

Most Popular Now

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...

New Research Shows Promise and Limitatio…

Published in JAMA Network Open, a collaborative team of researchers from the University of Minnesota Medical School, Stanford University, Beth Israel Deaconess Medical Center and the University of Virginia studied...

G-Cloud 14 Makes it Easier for NHS to Bu…

NHS organisations will be able to save valuable time and resource in the procurement of technologies that can make a significant difference to patient experience, in the latest iteration of...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

Hampshire Emergency Departments Digitise…

Emergency departments in three hospitals across Hampshire Hospitals NHS Foundation Trust have deployed Alcidion's Miya Emergency, digitising paper processes, saving clinical teams time, automating tasks, and providing trust-wide visibility of...

MEDICA HEALTH IT FORUM: Success in Maste…

11 - 14 November 2024, Düsseldorf, Germany. How can innovations help to master the great challenges and demands with which healthcare is confronted across international borders? This central question will be...

A "Chemical ChatGPT" for New M…

Researchers from the University of Bonn have trained an AI process to predict potential active ingredients with special properties. Therefore, they derived a chemical language model - a kind of...

Siemens Healthineers co-leads EU Project…

Siemens Healthineers is joining forces with more than 20 industry and public partners, including seven leading stroke hospitals, to improve stroke management for patients all over Europe. With a total...

MEDICA and COMPAMED 2024: Shining a Ligh…

11 - 14 November 2024, Düsseldorf, Germany. Christian Grosser, Director Health & Medical Technologies, is looking forward to events getting under way: "From next Monday to Thursday, we will once again...

In 10 Seconds, an AI Model Detects Cance…

Researchers have developed an AI powered model that - in 10 seconds - can determine during surgery if any part of a cancerous brain tumor that could be removed remains...